| Name | ceftazidime pentahydrate |
|---|---|
| Synonyms |
MFCD00153936
EINECS 276-715-9 Pyridinium, 1-[[(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt (6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Ceftazidime |
| Description | Ceftazidime pentahydrate (GR20263 pentahydrate) is a third generation cephalosporin administered intravenously or intramuscularly. Ceftazidime pentahydrate has a broad spectrum of in vitro activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime pentahydrate is particularly active against Enterobacteriaceae (including beta-lactamase-positive strains) and is resistant to hydrolysis by most beta-lactamases[1]. |
|---|---|
| Related Catalog | |
| References |
| Melting Point | >150ºC(dec.) |
|---|---|
| Molecular Formula | C22H32N6O12S2 |
| Molecular Weight | 546.576 |
| Exact Mass | 546.099121 |
| PSA | 244.76000 |
| LogP | -2.84 |
| Storage condition | 2-8°C |
| Hazard Codes | Xn: Harmful; |
|---|---|
| Risk Phrases | R42/43 |
| Safety Phrases | 22-36/37-45-37-24 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 1 |
| HS Code | 2941905990 |
| HS Code | 2941905990 |
|---|